LIVE #WCLC26 — live KOL coverage of the World Conference on Lung Cancer View Full Coverage →
KOL Pulse

AI in Oncology — KOL Digest

KOL DigestWednesday, August 12, 2026 All editions →

AI is replacing the reference tools, and the journals are setting limits

In this edition: Aaron Goodman, MD on AI replacing UpToDate · David S. Hong, MD on building his own RAS dashboard · Noah Lindenberg, MD on the limits of OpenEvidence · Yüksel Ürün, MD on where JAMA draws the line between AI assistance and authorship · Hashem El-Serag, MD on JAMA's new manuscript guidance · The ASCO Post on a study in which physicians kept following incorrect AI classifications.

Clinical reference toolsOpenEvidencePhysician-built AI toolsAI authorship & journal policyJAMA guidanceAutomation bias
Aaron Goodman, MD — profile photo, @Papa_Heme on X
Aaron Goodman, MD@Papa_Heme on X
Hematologist. Blood and marrow transplant and cellular therapy, Sarah Cannon / MountainView, Las Vegas.
UpToDate is going the way of the old medical textbook. They have been taking our money for long enough. Nice to see it being replaced by easy to access free information.
Illustration of a heavy, worn leather-bound book with brass clasps embossed with the word UpToDate, resting on a dark wooden desk beside an open antique anatomy textbook showing hand-drawn engravings of a skull and musculature.
View post on X ↗
David S. Hong, MD — profile photo, @DavidHongMD on X
David S. Hong, MD@DavidHongMD on X
Medical oncologist. Professor and Deputy Chair, Department of Investigational Cancer Therapeutics — the Phase I program — at MD Anderson Cancer Center.
Created this RAS dash board through Claude code-check it out and let me know if I should add or modify anything:claude.ai/code/artifact/… ↗
View post on X ↗
Noah L. Lindenberg, MD — profile photo, @nlindenberg on X
Noah L. Lindenberg, MD@nlindenberg on X
Hematologist-oncologist. Medical Director of the Lindenberg Cancer & Hematology Center, a private practice in Marlton, New Jersey.
Open evidence is a great resource if used properly however the same can be achieved independently. We are working on a product that will have international implications. x.com/Papa_Heme/stat… ↗
View post on X ↗
Free Access · KOL Pulse Intelligence

Track oncology’s top KOLs in your specialty

Create a free account, pick the tumor types you cover, and go beyond the tweet — the intelligence pharma teams use to map influence and prepare for engagement:

  • Enhanced KOL profiles
  • Pharma influence & potential advisory-board patterns
  • 2025 Open Payments financial analysis
  • Social-media sentiment & trend signals
Get free access — pick your specialty
Choose the tumor types you follow. No cost, unsubscribe anytime.
Yüksel Ürün, MD — profile photo, @DrYukselUrun on X
Yüksel Ürün, MD@DrYukselUrun on X
Genitourinary medical oncologist — prostate, kidney, bladder and testicular cancer. Professor of Medical Oncology, Ankara University Faculty of Medicine.
AI is already in the manuscript. The rules are still catching up. @JAMA_current draws a clear line between assistance and authorship, but that line will keep moving.....
jamanetwork.com/journals/jama/… ↗
Table headed 'JAMA Network Journals Guidance for Acceptable Use of AI', listing use types against whether each is acceptable. Research, literature search, manuscript preparation, translation and formatting or graphic visualisation of data are permitted provided the use is fully described and authors take full responsibility for all content; checking grammar or spelling is permitted with no disclosure needed; bibliographic references are discouraged. Presenting AI-generated data as original research, drafting letters, online comments or Opinion manuscripts, clinical images and illustrations, clinical video and audio, peer review, and author responses to reviewers are all marked No, with peer review noted as a violation of confidentiality.
Table from the JAMA Network journals' guidance on acceptable use of AI, linked in the post.
View post on X ↗
Hashem B. El-Serag, MD, MPH — profile photo, @SeragHashem on X
Hashem B. El-Serag, MD, MPH@SeragHashem on X
Gastroenterologist and hepatologist. Professor and Chair of the Department of Medicine and Vice President for the Learning Health System at Baylor College of Medicine. Past President of the American Gastroenterological Association.
JAMA published guidelines of using AI in submitted manuscripts linkedin.com/posts/guidogiu… ↗
View post on X ↗
The ASCO Post — profile photo, @ASCOPost on X
The ASCO PostPublication@ASCOPost on X
Oncology and hematology news publication, produced in partnership with ASCO and published by Harborside / Conexiant. A publication, not an individual clinician.
🖥️ #ASCOAI: A new experimental study highlights a challenge for clinical AI: automation bias may persist even with outcome feedback.

Physicians continued to follow incorrect AI-generated patient classifications across 2 simulated experiments.

🔗 ascoai.org/articles/2026/… ↗
View post on X ↗
Compiled and reviewed by the KOL Pulse research team, led by Brian Shields, Founder, KOL Pulse. Quotes are verbatim from their authors’ public posts on X. Last updated August 12, 2026.